Elite Pharmaceuticals and Cumberland Pharmaceuticals follow different growth paths, but which looks

/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./ PR Newswire NASHVILLE, Tenn., July 13, 2026

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE PR Newswire NASHVILLE, Tenn

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), an innovation-focused biopharmaceutical company devel

Record Date is July 10, 2026 & Payment Date is July 31,2026 Corporate and Insider Share Purchase Ini

$100 million Transaction Follows Cumberland Shareholder Approval Strengthens Cumberland's Focus on R

TORONTO, July 1, 2026 /PRNewswire/ - Apotex Health Corp. ("Apotex") (TSX: APTX), the largest Canadia

Cumberland Pharma shares rose after Phase 2 data showed ifetroban improved heart function in Duchenn

Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dys

Additional cardiac biomarker analyses further demonstrate ifetroban's cardioprotective effect in DMD

$6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon

$6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon

The U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to opagan

The U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to opagan

RALEIGH, N.C. and TEL-AVIV, Israel, June 8, 2026 /PRNewswire/ -- RedHill Biopharma Ltd.

https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/

CPIX reports positive Phase 2a results for Ifetroban, showing a favorable safety profile and promisi

CPIX launches Vibativ in China through SciClone, expanding access to its antibiotic treatment for se

Positive Results from Phase 2a Clinical TrialStudy met its primary endpoint demonstrating safety and

Positive Results from Phase 2a Clinical Trial Study met its primary endpoint demonstrating safety an

Amid the rapidly evolving Ebola virus disease (EVD) outbreak involving the rare Bundibugyo ebolaviru

Commercialization in China through partnership with SciClone Pharmaceuticals Expands access to poten

Shares of elf Beauty Inc (NYSE: ELF) rose sharply in pre-market trading after beating analyst expect

CPIX posts a wider y//y loss in Q1, as it unveils a $100-million Apotex deal and sharpens focus on o

Cumberland Pharmaceuticals Inc. (CPIX) Q1 2026 Earnings Call Transcript

Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.13) per share. This is a 181.25 percent de

Enters into Strategic Transaction, unlocking $100 million in value Sharpens focus on Orphan Drug can

Shares of Sterling Infrastructure Inc (NASDAQ: STRL) jumped 22.5% in pre-market trading after report

US stocks down, Nasdaq falls 0.4% on Thursday. Jobless claims rise to 214,000. Utilities jump 2.1%,

Dow Jones drops 0.44%, NASDAQ falls 0.31%, S&P 500 down 0.22%. Tesla shares drop 1% after report

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a U.S. specialty pharmaceutical company, today announ

Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.01) per share. This is a 50 percent increa

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company focused on develop

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), today announced an important update regarding its Cal

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

  During Wednesday's session, 212 companies made new 52-week lows.

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

  Wednesday's session saw 269 companies set new 52-week lows.